Complete response to preoperative chemoradiation and survival in esophageal cancer: A pooled analysis of three single-institution phase II trials

Diseases of the Esophagus

Volumn 25, Issue 2, 2012, Pages 130-136

  Orditura, M ^a   Galizia, G ^a   Morgillo, F ^a   Martinelli, E ^a   Lieto, E ^a   Vitiello, F ^a   di Martino, N ^a   Pacelli, R ^b   Renda, A ^b   Ciardiello, F ^a   de Vita, F ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Esophageal cancer; Pooled analysis; Preoperative chemoradiotherapy

Indexed keywords

CETUXIMAB; CISPLATIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PREOPERATIVE PERIOD; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84857113777     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01220.x     Document Type: Article

References (29)

1. Parkin D M, Bray F I, Devesa S S. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl 8): 64-6.
2. Associazione Italiana Oncologia Medica (AIOM). Tumori dell'esofago: linee guida. Available from URL:.
3. Ries L A G, Melbert D, Krapcho M etal. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute, 2008. Available from URL:, based on November 2007 SEER data submission, posted to the SEER web site.
4. Siewert J R, Stein H J, Feith M, Bruecher B L, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1, 000 consecutive resections at a single center in the Western world. Ann Surg 2001; 234: 360-9.
5. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P. A comparison of multimodal therapy and surgery for adenocarcinoma. N Engl J Med 1996; 335: 462-67.
6. Tepper J, Krasna M J, Niedzwiecki D etal. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer. CALGB 9781. J Clin Oncol 2008; 26: 1086-92.
7. Urschel J D, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-43.
8. Fiorica F, Cammà C, Venturi A etal. A preoperative chemotherapy and radiotherapy in patients with esophageal carcinoma: a meta-analysis. Gut 2004; 53: 925-30.
9. Gebsky V, Burmeister B, Smithers B M, Foo K, Zalcberg J, Simes J. Survival benefit from neoadjuvant chemoradiotherapy or chemotherapy in esophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-34.
10. Graham A J, Scrive F M, Ghali A etal. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg 2007; 83: 1257-64.
11. Lv J, Cao X F, Zhu B, Tao L, Wang D D. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol 2009; 15: 4962-68.
12. Berger A C, Farma J, Scott W J etal. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23: 4330-37.
13. Le Prise E, Etienne P L, Meunier B etal. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-84.
14. Bosset J, Gignoux M, Triboulet J etal. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-7.
15. Urba S G, Orringer M B, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-13.
16. Lee J L, Park S I, Kim S B etal. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004; 15: 947-54.
17. Burmeister B H, Smithers B M, Gebski V etal. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-68.
18. Stahl M, Stuschke M, Lehmann N etal. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-7.
19. Bedenne L, Michel P, Bouché O etal. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-8.
20. De Vita F, Di Martino N, Orditura M etal. Preoperative chemoradiotherapy for squamous cell and adenocarcinoma of the esophagus: A phase II study. Chest 2002; 122: 1302-08.
21. Orditura M, Galizia G, Napolitano V etal. Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer. Cancer Invest 2010; 28: 820-27.
22. De Vita F, Orditura M, Martinelli E etal. Neoadjuvant chemoradiation with FOLFOX 4 and Cetuximab in esophageal cancer: B152 phase II trial final results. Br J Cancer 2011; 104: 427-32.
23. Chan Y H. Biostatistics 203. Survival analysis. Singapore Med J 2004; 45: 249-56.
24. Mariette C, Seitz J F, Mailard E etal. Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase III trial FFCD 9901. J Clin Oncol 2010; 28: 15s. (suppl, abstract 4005).
25. Gaast A V, van Hagen P, Hulshof M etal. Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: results from a multicenter randomized phase III study. J Clin Oncol 2010; 28: 15s. (suppl, abstract 4004).
26. Geh J I, Crellin A M, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001; 88: 338-56.
27. Rice T W, Rusch V W, Apperson-Hansen C etal. Worldwide esophageal cancer collaboration. Dis Esophagus 2009; 22: 1-8.
28. Ruol A, Castoro C, Portale G etal. Trends in management and prognosis for esophageal cancer surgery Twenty-five years of experience at a single institution. Arch Surg 2009; 144: 247-54.
29. Geh J I, Bond S J, Bentzen S M, Glynne-Jones R. Systematic overview of preoperative (neoadjuvant) chemoradiation trials in oesophageal cancer: evidence of a radiation and chemotherapy dose-response. Radiother Oncol 2006; 78: 236-44.